Safety and Tolerability Study of Drug to Treat Schizophrenia
Clinical trial NCT00044005 · COMPLETED
Trial details
- NCT number
- NCT00044005
- Sponsor
- Sumitomo Pharma America, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2002-09-01
- Primary completion
- 2003-11-01
- Enrollment
- 98
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.